Repron Therapeutics
Epigenetic silencing platform for tumor recurrence repression. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$9—13m (Dealroom.co estimates Jun 2023.)
Milan Lombardy (HQ)
Authorizing premium user...